Datamonitor, May 2008, Pages: 26
. The report covers both life and non-life policyadministration. The report is globally orientated but speaks a great deal to the US and European market.
Highlights
Insurers must match innovation
Business Insights, Sep 2006, Pages: 137
face?
- How are insurers modernising their policyadministrationsystems?
- What do banks want their core systems architecture to look like in the future?
- What opportunities do hedge funds offer
Finaccord, Nov 2011
modules within creditor insurancepolicies is commonplace in Northern, Central and Eastern Europe;
- gain insight into the international presence of leading creditor insurance market participants including
Global Industry Analysts, Inc., March 2008, Pages: 620
The EuropeanInsurance Industry Report provides insightful analysis, market overview, industry structure and outlook of insurance industry in the region. Richly laden with quantitative analysis
Business Insights, June 2010, Pages: 125
reimbursement structure
US reimbursement payors
Public health insurance
Medicare
Medicaid
Other public systems
Private health insurance
Employer-sponsored insuranceAdministration
Financing
Private non
Global Industry Analysts, Inc., Sep 2008, Pages: 585
Consolidation Activity 9
EuropeanInsurers Pull Out from Foreign Markets 9
Emerging Markets 9
“Look East Policy” of Investors 9
Mix of the Strategies 10
Global Reinsurance Industry - A Review 10
Global
Global Industry Analysts, Inc., March 2008, Pages: 318
Industry AP-27
Presence of Foreign Insurance Companies in Australian
Insurance Industry AP-27
An Effective Distribution System
Finaccord, Sep 2008, Pages: 185
and Central Europe: this is turning into an increasingly mainstream market;
- assess the extent to which the provision of temporary incapacity and unemployment modules within creditor insurancepolicies
Global Industry Analysts, Inc., March 2008, Pages: 152
Fueled by Britain’s Growing Emigrant
Community UK-3
Growing Popularity of Annual InsurancePolicies to Drive
Travel
Decision Resources, Inc., June 2009, Pages: 31
will the healthcare system procure and use drugs on this list?
Scope
- Regulatory structure: key policy decision makers in the Chinese healthcare system.
- Organization and funding of the healthcare system
Decision Resources, Inc., Dec 2007, Pages: 32
will need to adapt to national reimbursement and prescribing policies on biosimilars. What policies are European countries taking with regard to biologics and biosimilars? What impact will reference pricing
Finaccord, Oct 2007, Pages: 185
incapacity and unemployment modules within creditor insurancepolicies is gaining ground in Eastern and South-Eastern Europe;
- identify partnership opportunities for creditor insurance and how these may
Espicom Business Intelligence Ltd, Nov 2011 SYSTEM
Organisation & administration
Health expenditure
- Expenditure by source of funding and type
Hospital services
- Hospital data such as beds by type, region, specialty, patient admissions
Business Insights, Oct 2010, Pages: 110
pricing system
Pricing and reimbursement in the UK
PPRS
NICE
Chapter 2 Impact of policy developments on market access
Summary
Introduction
US healthcare reform
CMS review of Provenge
Comparative
Decision Resources, Inc., March 2009, Pages: 48
are the targets of cost-containment? How do administrationpolicies present opportunity for the biopharma industry?
- Healthcare is generally regarded as a stable industry in a down economy, but biopharma
Milliman, April 2005
In most European countries, the Internet is still an insignificant distribution channel for life insurance business. However it already has impacted significantly the relationships between customers
Espicom Business Intelligence Ltd, Oct 2011
is estimated at 38.1 million in 2009 with nearly 13% of residents aged 65 years or over. Funding for healthcare in Poland is principally through the health insurancesystem. The National Health Fund
Spiramus Press, Dec 2011, Pages: 302
) and provides a guide to current trends, markets and policy choices facing governments and regulators. The book covers the way captives as well as open market insurers are regulated, how they operate and what
Business Insights, Nov 2009, Pages: 145
in the major European markets
Figure 4.14: The Japanese National Health Insurancesystem, FY2008
Figure 4.15: Average NHI price cuts, 1998-2008
Figure 4.16: Future scenarios for pharmaceutical pricing
Decision Resources, Inc., Aug 2008, Pages: 34
expenditures; relative importance of public and private health insurance; decentralization of responsibility for healthcare.
- Drug prices in Spain: comparison of launch prices in Spain and other European
